Topic Archives: Ginkgo BIoworks (DNA)

Luke Lango has a new “Next Microsoft” pitch for his entry-level growth-focused advisory Innovation Investor ($79/yr), here’s how his email a few days ago introduced the idea: “I don’t know about you, but I’m constantly looking for the ‘next big thing’ in the stock market. And I think synthetic biology might just be it. “Forget […]

Comments

  • Many thanks for another interesting appraisal. I greatly appreciate your work. Do you have any idea what stock Luke ...

  • I've speculated on Ginkgo options, haven't yet looked into the company beyond the article I wrote last week or read Scor...

  • Not a kind of Power REIT de ja vu for you? "2. Ginkgo’s business model is based on a dubious shell game. The majority ...

  • Ginkgo Bioworks (DNA) is indeed one of the stocks in Luke Lango's model portfolio. I have DNA shares in my portfolio, b...

  • Tough day today for DNA, looks like investors were not enthused with the new commitments Ginkgo made in their renewed su...

  • Cathie Wood commented on DNA a few days ago: "Shares of Ginkgo Bioworks shot up 22% Tuesday after the company beat reven...

  • Travis, FYI. Interesting hit piece here about Ginkgo. IMHO troubling related party games https://scorpioncapital.s3.us-e...

  • Confirmed, it is Ginkgo Bioworks (DNA)....

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info